Biography and Research Information
OverviewAI-generated summary
W. Du's research investigates the potential of nicotinamide riboside (NR) to alleviate cisplatin-induced peripheral neuropathy. Their work, published in 2022, demonstrates that NR activates SIRT2, a key enzyme involved in cellular regulation, to mitigate the nerve damage caused by cisplatin. This study was conducted in collaboration with Ratan Sadhukhan and Ravi P. Cholia at the University of Arkansas for Medical Sciences, with whom Du shares one publication. Du's recent activity indicates ongoing engagement in health sciences research.
Metrics
- Publications: 1
Selected Publications
-
Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation (2022)
Collaboration Network
Top Collaborators
- Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation
- Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation
- Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation
- Nicotinamide Riboside Alleviates Cisplatin-Induced Peripheral Neuropathy via SIRT2 Activation
Similar Researchers
Based on overlapping research topics